Dr. Jeffrey Lerner served as President and Chief Executive Officer of the ECRI Institute from November 2001 until he retired in December 2017. He is currently President Emeritus. 

Prior to becoming CEO he was Vice President for Strategic Planning beginning in 1984. He played the key role in setting the course for the institute’s transition from its origins as a medical device evaluation laboratory to a broader health research organization that assesses clinical procedures and drug therapies in addition to medical devices, worldwide.

Dr. Lerner was a member of the first Medicare Coverage Advisory Committee from 2001 until 2003, served on the Advisory Board of the U.S. Cochrane Collaboration Center, and was a Population Health Associate at Thomas Jefferson University. He is currently an Adjunct Senior Fellow of the Leonard Davis Institute of Health Economics of the University of Pennsylvania.  

Dr. Lerner previously served as principal investigator on assistive technology for the disabled projects for the U.S. Department of Transportation and the Easter Seals Society, and was a member of the Technical Board of the Milbank Memorial Fund in New York and a voting delegate of the United States Pharmacopeial Convention in Rockville, Maryland. He served on the Board of Directors of the Philadelphia Academies, Inc., a program for high school students living in poverty areas, and is a former President of the Board of the Health Strategy Network, a society of healthcare planners and managers.

Additionally, Dr. Lerner was associate editor of the Journal of Ambulatory Care Management, and the reviewer for numerous journals. He published articles in many journals, including Health Affairs. Throughout his career, he worked closely with the leadership of the National Institute of Drug Abuse, NIH, FDA, CMS, the VA, DOD, AHRQ, PCORI and additional agencies and national organizations.

Dr. Lerner received his MA and PhD from Columbia University, his BA is from Antioch College, and his business training is from the Wharton School.